Abstract
Introduction
The 'reaction' of a cell in the face of a DNA-damaging situation is an essential condition for its survival. There are five main DNA repair pathways that can be activated, depending on the type of induced damage: direct or reversion repair by O 6 [1] [2] [3] [4] [5] [6] . Additionally, there exist a DNA replication block bypassing repair mechanism termed post-replication repair (PRR), consisting of both error-prone translesion synthesis (TLS) and error-free damage avoidance [7] , as well as a DNA-crosslink repair pathway, combining HR and TLS, the Fanconi anaemia pathway (FA) [8] . The [9] . [10] [11] [12] [13] . In an expanding outlook of the ubiquity protein family there are several Ub-like proteins, sharing similarities in both structure and activation process, mainly represented by the small ubiquitin-like modifier (SUMO) protein and neural precursor cell expressed, developmentally down-regulated protein 8 (NEDD8) [14] . [15] [16] [17] [18] [19] . Remarkably, even a feedback mechanism between protein synthesis and degradation via transcriptional regulation of ribosomal protein genes by the proteasome has been implied [20, 21] [16, [22] [23] [24] [25] [26] [27] . Moreover, UV irradiation induces the degradation of CSB via the UPS in a CSA-dependent manner, after the completion of repair and this is considered a crucial step in the post-TCR resumption of transcription at a normal rate [28] . Reversal of yeast RNA pol II ubiquitylation was recently found to be effected by the Ub protease Ubp3 [29] . Most recent data are suggestive of a timely regulation of the entire process of TCR, [34] . Finally, pol II as well as topoisomerases 2␣ and 2␤ (which are discussed below) belong to a group of transcriptional and repair factors that have been found to interact with NEDD8 in proteomic analyses with the use of affinity purification and tandem mass spectrometry [35, 36] . [51] . This is in line with a feedback loop acting on p53 (clearly justified, taking into account that Rad23 has been shown to promote p53-degradation). [52] . This is also the case for BRCA1 [52] , however, the above-mentioned data only slightly illustrate its contribution in transcriptional DNA repair regulation, which is best described below.
-methylguanine DNA methyltransferase (MGMT), mismatch repair (MMR), baseexcision repair (BER), nucleotide-excision repair (NER), separated into global genomic repair (GGR) and transcription-coupled repair (TCR) and double-strand breaks repair (DSBR), which involves homologous recombination (HR) and non-homologous end joining (NHEJ) repair sub-pathways

The ubiquitin-proteasome system (UPS) is long known as a cellular tool for the marking and proteolytic degradation of proteins involved in a wide variety of structural and functional roles inside the cell. The UPS includes the 'ubiquitously' expressed 76-amino acid protein ubiquitin (Ub), the multi-subunit protein organelle 26S proteasome, consisting of one 20S catalytic and two 19S regulatory subunits, and finally, a three-step enzymatic cascade of Ub-activating (E1), Ub-conjugating (E2) and Ub-ligase (E3) enzymes that attach Ub to the target protein
An increasing amount of evidence supports the involvement of UPS in neoplastic formation and oncogenesis, via dysregulation of either proteasome-dependent degradation or/and Ub-and Ub family-related signalling. There are many examples demonstrating this causative relation, as a great number of cellular proteins with various roles have a close structural or functional connection with abnormally Ub-or Ub-like ligases, deubiquitinating enzymes and UPS-regulated signalling factors and pathways (such as p53 and NF-B)
Protein-DNA adducts repair
A more deep insight into the potential mechanisms of p53-mediated interference of UPS with DNA repair was offered by a study of Zhu et al (2007 [58, 59] [62] or/and negative regulation of basal levels of p21 [63] . Additionally to the p53-dependent transcriptional induction of GADD45, a p53 independent mechanism that is regulated by BRCA1 has also been suggested, via physical association of the latter with a transactivation domain on the GADD45 promoter and specific transcription factors [31] . BRCA1 has been found to play several regulatory roles in DNA-damage repair, transcription and cell cycle control, part of which are accomplished through stimulation of the p53-transcription activity [31, 32] , with DDB2 gene upregulation being a striking, well-described example [64] . More importantly, the final effect of this BRCA1 involvement is a redirection of the profile of p53-transactivated genes from proapoptotic to DNA repair-and growth arrest-related [31, 65, 66] . [67] . [68] . The accumulation of PPM1D after transactivation by p53 also results in inhibition of the latter, thus proposed to enable the cell to re-enter the cell cycle and render the DNA repair procedures less active [68] .
that causes cell cycle arrest and functions in excision repair pathways (BER, NER) via binding to proliferating cell nuclear antigen protein (PCNA) [58-61]. A further contribution of GADD45 to the enhancement of GGR sub-pathway of NER might be mediated by facilitation of chromatin-DNA repair protein interactions
Furthermore, the implication of UPS in BRCA1-mediated DNA repair transcriptional regulation may be further enriched by the evidence that interaction of BRCA1 with SUMO1 suppresses transcription of BRCA1-target genes (including GADD45) in a SUMOylation independent, histone deacetylase 1 (HDAC1)-dependent manner. This is best illustrated in a proposed model where SUMO1 modulates the occupancy of the promoter of BRCA1-target genes by causing disassembly of BRCA1 and assembly of HDAC1, thus reducing the level of acetyl-histones. When DNA damage occurs, this model is reversed and BRCA1 is recruited whereas SUMO1 and HDAC1 are released from the promoter
Moving back to our previous report on p53-regulated genes of NER and BER pathways, (protein phosphatase magnesiumdependent 1 delta (PPM1D) is a recently identified p53-transcriptional target that was surprisingly found to directly interact with the activated BER enzyme Uracil DNA glycosylase 2 (UNG2) causing its dephosphorylation and subsequent decrease in UNG2-associated BER activity
Finally [69] . [70, 71] and serial analysis of binding elements technology [72] . Subsequent confirmation of induction was performed with forced p53 expression using transfection models [70, 71] and p53-activating DNA-damaging drugs [72] . [73, 74] , possibly without binding of p53 to MGMT promoter [74] . [76] .
MMR pathway
Transcriptional regulation of MMR by UPS in a p53-inducible manner has been demonstrated with regard to MutS homolog 2 (MSH2), PMS2 post-meiotic segregation increased 2 (PMS2) and MutL homolog 1 (MLH1) genes via identification of p53-response elements in the promoter regions of the respective genes
MGMT repair pathway
There are a couple of potential mechanisms of transcriptional regulation of the direct repair (MGMT) pathway orchestrated by UPS. MGMT follows an inducible pattern similar to the p53-regulatory model described above. In specific, it was found that MGMT mRNA and protein are induced by IR only in wild-type p53-expressing cells of mice and rat and this effect is mediated by MGMT promoter activation based on transfection of MGMT-promoter constructs into p53-wild-type, mutant and deficient cells. However, the effect of p53 on MGMT expression appears to be dual, as the former suppresses basal MGMT promoter activity when overexpressed in cells upon transfection with p53 expression vector
A later study in human tumour cell lines is also in line with this argument, concluding that overproduction of wild-type p53 protein in human tumours curtails the transcription of the MGMT gene and confers a MGMT-deficient phenotype [75]. More recent data from experiments on astrocytic cells confirm the direct interaction between p53 and the MGMT promoter, further showing that disruption of p53 in a glioblastoma cell line resulted in significant reduction of MGMT expression without affecting promoter methylation that is a common incidence in these tumours
According to another model, DNA damage, induced by alkylating agents, causes increased MGMT expression via induction of the transcription factor Nuclear factor B (NF-B) p65, which was demonstrated to interact with two putative NF-B binding sites within the MGMT promoter [77] . But where does the UPS fit in and how can such a speculation be justified? Following genotoxic stress, the regulatory subunit of cytoplasmic IB kinase complex, [78, 79] . Another way of NF-B activation from UPS is the 26S proteasome-mediated cleavage of NF-B prodromal forms p105 and p100, to generate p50 and p52, respectively [80] [81] [82] [83] 
IKK␥ or NEMO (NF-B essential modulator) is translocated to the nucleus and consecutively subjected to SUMOylation, ATM (ataxiatelangiectasia mutated, a signal transducing kinase)-dependent phosphorylation, deconjugation of SUMO and ubiquitylation, thus facilitating its cytoplasmic re-localization, in order to activate NF-B. This activation is effected through phosphorylation and ubiquitination of the NF-B inhibitory proteins IB-␣ and IB-␤. These proteins are substrates of 26S proteasome in a way that proteasomal degradation releases NF-B from its complex, facilitating its transport to the nucleus
. Among the various different NF-B heterodimer p50-p65-target genes, MGMT promoter becomes activated and the transcribed gene product repairs the DNA damage, O
6
-methylguanine [77] . This could be a possible explanation, featuring both proteolytic and non-proteolytic roles of UPS.
In the case of MGMT gene-induction, as well as for any DNA repair gene that is transcriptionally modulated by both p53 and NF-B, the plot gets thicker and more difficult to predict, considering data on the existence of interplay between these two major transcription factors. Both antagonistic and synergistic interactions exist, largely varying according to induced conditions and cell types [84] [85] [86] [87] [88] [89] .
DSBR pathway
Transcriptional induction of other DNA repair factors by NF-B at a constitutive level has also been implicated for NHEJ proteins Ku70 and Ku80, in a cyclooxygenase-2 (COX-2)-dependent mechanism [90]. This suggestion was based on the observation that acinar gastric cells with low constitutive NF-B p50 levels had lower expression of both Ku70 and Ku80. Furthermore, the use of COX-2 a well-known NF-B-target protein) inhibitors suppressed while prostaglandin E2 (PGE2)-enhanced Ku70 and Ku80 expression in cells with low constitutive NF-B level. The authors have also revealed a reverse pattern of NF-B/Ku interaction in which
Ku (Ku70-Ku80 heterodimer) acts as an upregulator of p50 transcription by interacting with the recombination signalling protein RBP-J (which binds to p50 promoter) [90] .
With [91] . This finding is of great importance, considering previous data about KARP-1 involvement in the regulation of DNA-PK activity [92] . More recently, Rad51 was added in the list of p53-dependent DSBR genes, revealed in an oligo-based array containing several promoters [Ceribeli 2006 ], and its expression was repressed as a response to DNA damage via a direct binding of p53 in the Rad51 promoter [93] . [99] . Proteasome inhibitor also prevented the increase in ERCC-1 mRNA expression that occurs in cells exposed to cisplatin [100, 101] . ERCC-1 protein is responsible for the excision of lesions processed by NER [2] . Finally, cells treated with the combination of proteasome inhibitor and cisplatin underwent apoptosis more quickly than cells treated with either agent alone [99] [100] [101] .
FA pathway
It [112] . [114] [115] [116] [117] [118] . The knowledge of molecular mechanisms underlying this combination treatment is the key to interpret and manipulate pharmacological knowledge and apply targeted drug therapies in the most beneficial way possible for patients.
Conclusions and future perspectives
